What’s new in pulmonary fibrosis treatment
Successful trials of new medications offer hope for people with pulmonary fibrosis.
Successful trials of new medications offer hope for people with pulmonary fibrosis.
Spirometry testing is necessary for an accurate diagnosis of chronic obstructive pulmonary disease (COPD) and is a cornerstone of optimised COPD management. A new report from the Australian Commission on Safety and Quality in Health Care (the Commission) highlights that the people who need it most are missing out.
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
A national clinical care standard is set to improve outcomes and reduce potentially avoidable hospital admissions for the incurable lung condition, chronic obstructive pulmonary disease (COPD).
InSight+ spoke with Dr Brett Montgomery about a “win-win” solution to improve asthma control for thousands of Australians while helping reduce the climate impact of asthma inhalers
Evidence-based communication approaches to raise awareness, promote preventive behaviours and attitudes toward respiratory wellbeing are needed to turn negative messages about lung disease into lung health for all.
Recent developments in the treatment of adult asthma could be adapted to treat suppurative lung disease and wheezing in children, according to new research from the Murdoch Children’s Research Institute.
The burden of bronchiectasis among Indigenous adults in the Top End of the Northern Territory is significant, but more research is needed to develop targeted strategies and close the health gap.